PTTHERAGNOSTIC
ptTheragnostic started as a spin-off company of Maastro clinic (MC) and Maastricht University Medical Center (MUMC) in 2014. The company was acquired in December 2015 by DNAmito Inc. based in Cupertino, California, bringing in necessary investments and an experienced management and commercialization team supported by world class clinical and product development teams. ptTheragnostic is initially based on the mitochondrial DNA assay, MitoTx™, to predict the risk for radiation-induced toxicity ... in patients that undergo radiotherapy. The company incorporated a second asset, PRODECIS™, which is a clinical decision support system to select the right patients for proton therapy. With these two assets ptTheragnostic aims to achieve more effective, individualised radiation therapy for cancer patients. Taken together, ptTheragnostic is the service company for patient stratification in radiotherapy. ptTheragnostic is a joint effort between MC and the MUMC. MC is one of Europe’s leading radiation therapy facilities. MC has ample expertise in dose modelling, imaging and developing prediction models for survival as well as toxicity outcomes. The research lab and the expertise in experimental design and data-analysis will be utilised via the unit Clinical Genomics of the Department of Clinical Genetics of the MUMC. The strength of this partnership is the unique multidisciplinary team that consists of clinicians, physicists and software developers. This team will conduct fundamental research and translate this into innovations with benefit for patients. Moreover, the MC and MUMC will also offer future IP assets with regard to ptTheragnostic’s services which allow further development and consolidation of the company.
PTTHERAGNOSTIC
Industry:
Biotechnology Health Care Home Health Care Medical
Founded:
2014-01-01
Address:
Maastricht, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.pttheragnostic.com
Total Employee:
1+
Status:
Active
Total Funding:
2.43 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy Starfield Technologies
Similar Organizations
Cizzle Biotech Ltd.
Cizzle Biotech Ltd. focuses on the development of CIZ1 gene and its potential as a diagnostic biomarker.
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - ptTheragnostic
Official Site Inspections
http://www.pttheragnostic.com
- Host name: 38.48.175.155
- IP address: 38.48.175.155
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "ptTheragnostic"
ptTheragnostic - Crunchbase Company Profile & Funding
PtTheragnostic focuses on the development of genomics-based personalized analysis for radiation sensitivity. ptTheragnostic started as a spin-off company of Maastro clinic (MC) and …See details»
ptTheragnostic Company Profile 2024: Valuation, Investors
PtTheragnostic General Information Description. Operator of a biotechnology company based in Maastricht, Netherlands. The company focuses on the development of genomics-based …See details»
ptTheragnostic - Crunchbase Company Profile & Funding
PtTheragnostic focuses on the development of genomics-based personalized analysis for radiation sensitivity.See details»
ptTheragnostic - Products, Competitors, Financials, Employees ...
PtTheragnostic is a spin-off from the Maastricht University, University Medical Center and Maastro Clinic. ptTheragnostic focuses on the development of genomics-based personalized analysis …See details»
ptTheragnostic - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 1, 2015: Grant - …See details»
DNAmito acquires ptTheragnostic - PR Newswire
Jan 11, 2016 ptTheragnostic is a spin-off from the Maastricht University, University Medical Center and Maastro Clinic. ptTheragnostic focuses on the development of genomics-based …See details»
ptTheragnostic BV - Company Profile and News - Bloomberg …
Company profile page for ptTheragnostic BV including stock price, company news, executives, board members, and contact informationSee details»
DNAmito Acquires ptTheragnostic - BioSpace
Jan 12, 2016 CUPERTINO, Calif. and MAASTRICHT, Netherlands, Jan. 11, 2016 /PRNewswire/ -- DNAmito Inc. announced today that the company has acquired ptTheragnostic Ltd in …See details»
ptTheragnostic BV: Drug pipelines, Patents, Clinical trials - Synapse
Jul 1, 2023 Explore ptTheragnostic BV with its drug pipeline, therapeutic area, technology platform, .See details»
ptTheragnostic - Crunchbase
PtTheragnostic focuses on the development of genomics-based personalized analysis for radiation sensitivity.See details»
ptTheragnostic Stock Price, Funding, Valuation, Revenue
See ptTheragnostic funding rounds, investors, investments, exits and more. Evaluate their financials based on ptTheragnostic's post-money valuation and revenue.See details»
Theranostics - Wikipedia
Theranostics, also known as theragnostics, [1] is a technique commonly used in personalised medicine.For example in nuclear medicine, one radioactive drug is used to identify and a …See details»
Essentials of Theranostics: A Guide for Physicians and Medical ...
Dec 7, 2023 Radiopharmaceutical therapies (RPTs) are gaining increased interest with the recent emergence of novel safe and effective theranostic agents, improving outcomes for …See details»
Nuclear Cancer Treatment - United Theranostics
United Theranostics is a national private practice dedicated to addressing the current major challenge of meaningful access to radiopharmaceutical therapy and advanced molecular …See details»
Nuclear Medicine and Cancer Theragnostics: Basic Concepts
Abstract. Cancer theragnostics is a novel approach that combines diagnostic imaging and radionuclide therapy. It is based on the use of a pair of radiopharmaceuticals, one optimized …See details»
ptTheragnostic - Tech Stack, Apps, Patents & Trademarks
Organization. ptTheragnostic . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 8. About. …See details»
Theranostics - UChicago Medicine
Theranostics is a growing field that's showing significant improvement for many cancer types, including thyroid, neuroendocrine, prostate, and neuroblastoma.See details»
Theranostics in Nuclear Medicine: Emerging and Re-emerging …
Oct 1, 2020 Theranostics refers to the pairing of diagnostic biomarkers with therapeutic agents that share a specific target in diseased cells or tissues. Nuclear medicine, particularly with …See details»
Evergreen Theragnostics Expands Alpha Radiopharmaceutical …
Evergreen Theragnostics, established in 2019, is a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). With a state-of-the-art global …See details»
Why should we be concerned about a “g”? - Springer
Nov 6, 2018 In recent years there has been much debate regarding whether we should use the term “theranostics” or “theragnostics”. Both have a long history of use [1, 2] and it is generally …See details»